43 studies found for:    " March 26, 2008":" April 25, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" March 26, 2008":" April 25, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy
Condition: HIV-Associated Lipodystrophy Syndrome
Interventions: Drug: Standard continuous antiretroviral therapy;   Drug: CD-4 guided therapy interruption;   Drug: Viral load driven treatment interruption
2 Unknown  Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone
Conditions: HIV Infections;   HIV-Associated Lipodystrophy Syndrome
Intervention:
3 Completed Sex, Aging and Antiretroviral Pharmacokinetics
Condition: HIV Infections
Intervention: Drug: ARV regimen chosen by treating physician
4 Completed Raltegravir as Early Therapy in African-Americans Living With HIV Study
Condition: HIV Infections
Intervention: Drug: Raltegravir + Truvada
5 Completed Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: rifabutin in combination with lopinavir boosted by ritonavir - dosing schedule 1;   Drug: rifabutin in combination with lopinavir boosted by ritonavir - dosing schedule 2
6 Completed Pharmacokinetic Study of Two Generic co-Formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)
Condition: HIV Infections
Intervention: Drug: Lopinavir/ritonavir
7 Completed Evaluation of 2 Interferon γ Assays in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOT
Conditions: HIV Infections;   Tuberculosis
Interventions: Device: QuantiFERON TB Gold In-Tube;   Device: T-SPOT.TB®
8 Active, not recruiting Prospective Observational Epidemiologic Study of Maraviroc's Safety
Condition: Human Immunodeficiency Virus
Interventions: Drug: Maraviroc along with an optimized background antiretroviral drug regimen;   Drug: Optimized background antiretroviral drug regimen without maraviroc
9 Completed
Has Results
Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome
Conditions: HIV Infections;   Cardiovascular Disease;   Insulin Resistance;   HIV Lipodystrophy;   The Metabolic Syndrome
Interventions: Drug: Pioglitazone;   Behavioral: Exercise Training
10 Recruiting Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV)
Conditions: HIV-hepatitis Co-infection;   HIV Infections
Intervention:
11 Completed Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects
Condition: HIV Infections
Interventions: Drug: Raltegravir and Lopinavir/ritonavir;   Drug: Raltegravir, emtricitabine, tenofovir
12 Suspended Bioequivalence Study of Didanosine in Children Treated for HIV
Condition: HIV Infections
Intervention: Drug: didanosine
13 Completed
Has Results
Raltegravir Therapy for Women With HIV and Fat Accumulation
Conditions: HIV Infections;   Lipodystrophy
Intervention: Drug: raltegravir
14 Unknown  Effectiveness of Interactive Virtual Environment Games in Reducing Risky Sexual Behavior Among Men Who Have Sex With Men (The SOLVE-IT Study)
Condition: HIV Infections
Intervention: Behavioral: Socially Optimized Learning in a Virtual Environment (SOLVE)-IT
15 Completed Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF)
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Emtricitabine/tenofovir disoproxil fumarate
16 Unknown  A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients
Conditions: HIV Infections;   Hepatitis B Virus
Intervention:
17 Active, not recruiting Molecular Diversity of HIV-1 Group O Strains and Treatment Management in Cameroon
Condition: HIV Infections
Interventions: Drug: Treatment initiation for HIV-1 group O infected patients;   Drug: Treatment initiation for HIV-1 group M infected patients
18 Completed TMC114-C213: A Phase II Randomized, Controlled, Partially Blinded Trial to Investigate Dose-response of TMC114/RTV in 3-class-experienced HIV-1 Infected Patients, Followed by an Open-label Period on the Recommended Dose of TMC114/RTV.
Condition: HIV
Intervention: Drug: TMC114; darunavir; Prezista
19 Completed
Has Results
Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection
Conditions: HIV Infections;   Hepatitis B
Interventions: Drug: Entecavir with continued standard of care antiretroviral therapy;   Drug: continued standard of care with tenofovir in addition to emtricitabine or lamivudine
20 Completed
Has Results
HIV Screening in the Emergency Department Setting
Condition: HIV Infections
Interventions: Other: Targeted Screening;   Other: Routine Screening

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years